Skip to main content
Premium Trial:

Request an Annual Quote

Danaher: Jennifer Honeycutt

Danaher announced it has appointed Jennifer Honeycutt as executive VP, responsible for Beckman Coulter Life Sciences, Integrated DNA Technologies, Leica Microsystems, Molecular Devices, Pall, Phenomenex, and Sciex. Previously, Honeycutt was a VP and group executive overseeing Pall, IDT, and the Danaher Life Sciences platform in China, as well as the president of Pall. From 2013 to 2016, she was president of Beckman Coulter Life Sciences. She joined Danaher in 1999 and served in general management roles at Hach Ultra Analytics, Anderson Instrument Company, and Linx Printing Technologies.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.